Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05201781 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Name: A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel — clinical trial record (NCT05201781)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorJanssen Research & Development, LLC

Started2022-03-09

View on ClinicalTrials.gov ↗

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.

Amendment history 3 changes detected by DataLookout

2026-08-29

Completion moved earlier: 2042-06-01 → 2041-06-28

2026-05-09

Completion pushed: 2038-01-26 → 2042-06-01

2026-04-14

Completion pushed: 2037-10-30 → 2038-01-26

Trial Details

NCT Number	NCT05201781
Lead Sponsor	Janssen Research & Development, LLC
Conditions	Multiple Myeloma
Enrollment	295 participants
Start Date	2022-03-09
Primary Completion	2037-07-29 (estimated)
Study Completion	2041-06-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-28